Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$90.05

0.48 (0.54%)

08:06
07/19/18
07/19
08:06
07/19/18
08:06

Eli Lilly, Boehringer Ingelheim report CARMELINA trial met primary endpoint

CARMELINA, the "CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk" trial, met its primary endpoint, defined as time to first occurrence of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke, with Tradjenta demonstrating similar cardiovascular safety compared with placebo, reported Boehringer Ingelheim and Eli Lilly. The trial, which evaluated the impact of treatment with Tradjenta compared with placebo on cardiovascular safety on top of standard of care, included 6,979 adults with type 2 diabetes and high cardiovascular risk. The majority of patients also had kidney disease, an important risk factor for cardiovascular disease. The overall safety profile of Tradjenta in CARMELINA, including adults with kidney disease, was consistent with previous data, and no new safety signals were observed. "Tradjenta demonstrated cardiovascular safety in adults with type 2 diabetes and high vascular risk, with no need for dose adjustments regardless of kidney function. CARMELINA provides confidence in Tradjenta as an effective and well-tolerated treatment, with a simple dosing regimen, for adults with type 2 diabetes," said Jeff Emmick, vice president, Product Development, Lilly Diabetes. The full results of CARMELINA will be presented on Oct. 4 at the 54th European Association for the Study of Diabetes Annual Meeting.

  • 24

    Jul

  • 10

    Sep

LLY Eli Lilly
$90.05

0.48 (0.54%)

07/18/18
WELS
07/18/18
NO CHANGE
WELS
Novartis report has negative read through for Teva, Mylan, says Wells Fargo
Wells Fargo analyst David Maris noted that Novartis (NVS) lowered its 2018 guidance for Sandoz along with its Q2 report and reportedly told Bloomberg that it would consider selling the generic drug unit. He sees a negative read through for companies with large U.S. commodity generic exposure, such as Teva (TEVA) and Mylan (MYL), from Novartis' report, Maris tells investors. He also noted that Novartis said it will not increase prices on its drugs in the U.S. for the rest of 2018, as Pfizer (PFE) recently has also said, calling this "a wise approach and correct read of the increasing intensity of the scrutiny around rising healthcare costs." Maris continues to expect the " chilling effect" on price increases to spread through the industry. Lastly, the analyst pointed out that the Amgen-partnered (AMGN) launch of Aimovig is off to a strong start, which he believes bodes well for Teva's fremanezumab and Eli Lilly's (LLY) galcanezumab.
07/18/18
PIPR
07/18/18
NO CHANGE
Target $450
PIPR
Overweight
Piper maintains Overweight on Regeneron on tanezumab news
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on Regeneron Pharmaceuticals (REGN) on news that tanezumab, Pfizer (PFE) and Eli Lilly's (LLY) anti-NGF antibody that is a competitor to Regeneron's fasinumab, successfully completed the first of several Phase 3 trials. Fasinumab remains an unmodeled opportunity, but the read-through from tanezumab is positive and the market for an effective, non-opioid chronic pain treatment is "massive," Raymond tells investors in a research note. The analyst points out that Regeneron and Teva (TEVA) still expect to report Phase 3 data starting later this year. Raymond keeps an Overweight rating on Regeneron with a $450 price target.
07/17/18
CANT
07/17/18
NO CHANGE
CANT
Overweight
Aclaris offers best risk/reward of hair loss players, says Cantor Fitzgerald
The potential for JAK inhibitors to treat alopecia areata may be underappreciated by investors because the Street does not appear to be ascribing enough value to the opportunity, Cantor Fitzgerald analyst Louise Chen tells investors in a research note. Of the three companies she covers developing JAKs for hair loss, Aclaris Therapeutics (ACRS), Eli Lilly (LLY) and Pfizer (PFE), the analyst believes Aclaris offers the best risk/reward and greatest upside potential. The company has a market cap below $700M and two potential "shots on goal" for alopecia areata, Chen writes. She estimates combined peak sales of $1B-plus for both opportunities and keeps an Overweight rating on Aclaris. The physicians the analyst spoke to believe the company's JAKs for hair loss will work.
07/17/18
MZHO
07/17/18
INITIATION
Target $26
MZHO
Buy
Mizuho starts Xeris Pharmaceuticals with Buy rating, $26 target
Mizuho analyst Difei Yang last night initiated coverage of Xeris Pharmaceuticals with a Buy rating and $26 price target. The company offers a potentially superior solution for the treatment of severe hypoglycemia compared to the standard of care - Eli Lilly's (LLY) glucagon emergency kit, Yang told investors in a research note. The analyst sees a "significant growth opportunity" for the ready-to-use glucagon rescue pen as more healthcare professionals prescribe an easier option for patients with diabetes at risk of severe hypoglycemia.

TODAY'S FREE FLY STORIES

TGTX

TG Therapeutics

$7.12

0.22 (3.19%)

18:57
05/23/19
05/23
18:57
05/23/19
18:57
Hot Stocks
TG Therapeutics CEO: We're a bit of an unconventional company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

SQM

SQM

$30.86

-1.82 (-5.57%)

18:57
05/23/19
05/23
18:57
05/23/19
18:57
Downgrade
SQM rating change  »

SQM downgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SQM

SQM

$30.86

-1.82 (-5.57%)

18:51
05/23/19
05/23
18:51
05/23/19
18:51
Downgrade
SQM rating change  »

SQM downgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

VSAT

ViaSat

$87.89

-1.63 (-1.82%)

, DECK

Deckers Brands

$147.27

-2.94 (-1.96%)

18:50
05/23/19
05/23
18:50
05/23/19
18:50
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Viasat…

VSAT

ViaSat

$87.89

-1.63 (-1.82%)

DECK

Deckers Brands

$147.27

-2.94 (-1.96%)

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

INTU

Intuit

$241.30

-6.22 (-2.51%)

NVCR

Novocure

$49.40

-1.92 (-3.74%)

CTL

CenturyLink

$9.66

-0.29 (-2.91%)

ADSK

Autodesk

$169.64

-4.47 (-2.57%)

LGF.A

Lionsgate

$15.96

-0.06 (-0.37%)

ROST

Ross Stores

$94.54

-0.06 (-0.06%)

SPLK

Splunk

$128.68

-7.12 (-5.24%)

HPE

HP Enterprise

$14.33

-0.21 (-1.44%)

DVAX

Dynavax

$6.36

(0.00%)

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 10

    Jun

  • 12

    Jun

  • 13

    Jun

  • 17

    Jun

  • 09

    Jul

EPE

EP Energy

$0.16

(0.00%)

18:32
05/23/19
05/23
18:32
05/23/19
18:32
Hot Stocks
EP Energy suspends NYSE trading, begins trading on OTC markets »

EP Energy confirmed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$76.07

-0.28 (-0.37%)

, NFLX

Netflix

$352.23

-7.47 (-2.08%)

18:15
05/23/19
05/23
18:15
05/23/19
18:15
Hot Stocks
T-Mobile says new Magenta plan will include Netflix Basic for families »

T-Mobile (TMUS) said…

TMUS

T-Mobile

$76.07

-0.28 (-0.37%)

NFLX

Netflix

$352.23

-7.47 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 03

    Jun

  • 06

    Jun

  • 13

    Jun

  • 25

    Jun

HOPE

Hope Bancorp

$13.23

-0.5 (-3.64%)

18:06
05/23/19
05/23
18:06
05/23/19
18:06
Hot Stocks
Hope Bancorp names Kevin S. Kim chairman of the board »

Hope Bancorp, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CTL

CenturyLink

$9.66

-0.29 (-2.91%)

18:06
05/23/19
05/23
18:06
05/23/19
18:06
Hot Stocks
CenturyLink CEO buys 50K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXR

Extra Space Storage

$106.85

0.59 (0.56%)

18:00
05/23/19
05/23
18:00
05/23/19
18:00
Hot Stocks
Extra Space Storage raises quarterly dividend by 4.7% to 90c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 04

    Jun

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:58
05/23/19
05/23
17:58
05/23/19
17:58
Hot Stocks
HP Inc. says continue to expect FY19 free cash flow of at least $3.7B »

Guidance from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:57
05/23/19
05/23
17:57
05/23/19
17:57
Hot Stocks
HP Inc CFO sees FY19 tax rate of about 19% »

Says FY19 EPS outlook of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

BA

Boeing

$350.57

-1.93 (-0.55%)

17:56
05/23/19
05/23
17:56
05/23/19
17:56
Periodicals
FAA tells U.N. it sees 737 MAX approval as soon as late June, Reuters says »

FAA representatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

BA

Boeing

$350.57

-1.93 (-0.55%)

, UAL

United Continental

$80.91

-0.94 (-1.15%)

17:52
05/23/19
05/23
17:52
05/23/19
17:52
Periodicals
Airlines see 737 MAX needing 100-150 hours of preparation, Reuters says »

Officials from three U.S.…

BA

Boeing

$350.57

-1.93 (-0.55%)

UAL

United Continental

$80.91

-0.94 (-1.15%)

AAL

American Airlines

$29.49

-0.43 (-1.44%)

LUV

Southwest

$50.97

-1.6 (-3.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 12

    Jun

  • 12

    Jun

  • 25

    Jul

  • 13

    Nov

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:50
05/23/19
05/23
17:50
05/23/19
17:50
Hot Stocks
HP Inc CFO says continued to 'outperform PC market and gain profitable share' »

Says commercial portfolio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

TCCO

Technical Comm Corp

$3.48

(0.00%)

17:48
05/23/19
05/23
17:48
05/23/19
17:48
Hot Stocks
Technical Comm Corp receives compliance and plan acceptance notices from Nasdaq »

Technical Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$19.20

-0.095 (-0.49%)

17:42
05/23/19
05/23
17:42
05/23/19
17:42
Hot Stocks
HP Inc. says PC growth across industry was subdued this quarter »

Continue to gain momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

RST

Rosetta Stone

$24.93

1.135 (4.77%)

17:38
05/23/19
05/23
17:38
05/23/19
17:38
Hot Stocks
Rosetta Stone officer Sonia Galindo sells over $107K in company shares »

Rosetta Stone officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

CCF

Chase Corporation

$100.72

0.32 (0.32%)

17:32
05/23/19
05/23
17:32
05/23/19
17:32
Hot Stocks
Chase Corporation chairman sells 2K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNR

RenaissanceRe

$170.85

-0.34 (-0.20%)

17:24
05/23/19
05/23
17:24
05/23/19
17:24
Syndicate
Breaking Syndicate news story on RenaissanceRe »

RenaissanceRe files $750M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

17:21
05/23/19
05/23
17:21
05/23/19
17:21
Earnings
DXC Technology sees FY20 adjusted EPS $7.75-$8.50, consensus $9.21 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

RTIX

RTI Surgical

$4.40

-0.08 (-1.79%)

17:19
05/23/19
05/23
17:19
05/23/19
17:19
Syndicate
Breaking Syndicate news story on RTI Surgical »

RTI Surgical files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 17

    Jun

RTN

Raytheon

$179.79

-1.01 (-0.56%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Raytheon awarded $355.49M Navy contract for AGM-88B missiles »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

DVAX

Dynavax

$6.36

(0.00%)

17:15
05/23/19
05/23
17:15
05/23/19
17:15
Hot Stocks
Breaking Hot Stocks news story on Dynavax 

Dynavax trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

COST

Costco

$248.62

-0.93 (-0.37%)

17:11
05/23/19
05/23
17:11
05/23/19
17:11
Recommendations
Costco analyst commentary at Baird »

Baird recommends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.